Blue Charm Adherence Inc.

Blue Charm Adherence Inc. , based in Canada, specializes in digital health solutions that empower patients with chronic diseases to manage their health through innovative programs that offer monetary rewards for engagement. Founded in 2020 in Canada, Blue Charm Adherence Inc. focuses on enhancing health management for patients with chronic diseases through tailored digital programs.

The company has successfully raised USD 4. 00 mn in Seed funding, led by Credit Mutuel Equity and Invest Nova Scotia, with a total amount raised also standing at USD 4. 00 mn. The most recent funding round occurred on September 11, 2025.

Blue Charm operates within the digital health sector, offering innovative programs designed to empower patients with chronic diseases to manage their health effectively while providing monetary rewards for their participation. The core product offerings include programs tailored for various conditions such as Asthma, Multiple Sclerosis, Chronic Obstructive Pulmonary Disease (COPD), Inflammatory Bowel Disease (IBD), Severe Asthma, Obesity, and Type 2 Diabetes. Each program allows eligible participants to share their experiences through surveys and contribute valuable health data while earning financial incentives up to USD 120 e-transfer for healthcare services and expenses. These services are primarily targeted at individuals diagnosed with specific conditions who have valid prescriptions, facilitating improved health outcomes through active engagement in their treatment journeys.

Blue Charm's programs are available across Canada, catering to a diverse range of patients seeking support for their health conditions. Blue Charm's revenue model is built on facilitating transactions that reward patient engagement in health management. The company's structure revolves around direct-to-consumer interactions, where patients enroll in programs aligned with their health conditions and participate in surveys that yield insights for ongoing health research. Participants are incentivized with financial compensation for providing feedback, thereby creating a sustainable ecosystem where patients benefit from their involvement.

Each program has defined eligibility criteria and compensation levels, which may include up to USD 120 or USD 100 e-transfer based on the specific health condition being addressed. The revenue generated is closely linked to patient enrollment and participation rates within these programs, establishing a direct correlation between user engagement and the financial health of the company. In September 2025, Blue Charm Adherence Inc. raised USD 4.

00 mn in Seed funding, which will be utilized to support growth and product development initiatives. The company is focused on expanding its digital health programs into new geographic markets, though specific regions have yet to be disclosed. Upcoming product launches are also in the pipeline to enhance the offerings tailored for patients with chronic diseases.